2010
2010
|
2009
2009
|
2008
2008
|
2007
2007
|
2006
2006
|
2005
2005
Obtained Registration Certificate for Medical Device of Veloderm® in China
2010.01.29
Obtained Renewal of Imported Drug License for Co-dergocrine Mesylate in China
2010.01.15
Obtained Renewal of Imported Drug License for Ferplex® Iron Proteinsuccinylate Oral Solution in China
2010.01.14
Distribution Agreement signed to market Lercanidipine tablets in Hong Kong and Macau
2009.12.31
JENNEREX AND LEE’S PHARMACEUTICALS ANNOUNCE PARTNERSHIP FOR JX-594 IN CHINA
2009.11.23
Phase I Clinical Study on Antiplatelet Thrombolysin injection
2009.11.06
Lee's Pharmaceutical Enters into Agreement with Nippon Shinyaku A Move To Accelerate Market Diversification in China
2009.03.02
Anhui Government Official Visited Zhaoke Pharmaceutical (Hefei) Co. Ltd.
2008.12.22
Lee's Pharmaceutical Establishes New R&D Centre at the Hong Kong Science Park To Bolster the Group's R&D Capabilities
2008.12.17
New Drug Approval for Eyprotor® (Protein-free Calf Blood Extract Eye-gel) in China
2008.05.13
LEE'S SIGNED COLLABORATION AGREEMENT WITH NOVELOS
2007.12.19
SIGMA-TAU STRENGTHENS ITS PARTICIPATION IN LEE'S PHARMACEUTICALS
2007.09.20
Exclusive Distribution Agreement Signed for Aloxi® injection in China
2007.08.09
Completed the Pharmacokinetic Study of HIBOR® (Bemiparin Sodium)
2007.06.25
Distribution Agreement Signed with Italfarmaco of Italy for Serestill® in China
2007.06.18
Important milestones achieved in Clinical Studies of Stent & Balloon Catheter
2007.06.15
New Indication Approved for Cervicitis for Yallaferon
2006.10.18
Marketing Approval for Slounase® (Hemocoagulase) in China
2006.09.22
Approval to initiate a Clinical Trial for Hibor
2006.06.23
Approval for Clinical Study on Antiplatelet Thrombolysin injection
2006.02.20
Distribution agreement signed to market Propiverine Hydrochloride
2006.02.20
New Product Launch in Hong Kong - HIBOR® (Bemiparin Sodium)
2005.12.20
Completion of the Study of Yallaferon® in Cervicitis Patients
2005.12.20
New Drug Approval for Hemocoagulase snake venom
2005.10.17
Distribution of HORUS®S Coronary Stent
2005.09.28
New Indication Approved for Yallaferon®
2005.09.07
Distribution Agreement to market Somatostatin
2005.06.15
Complete patients recruitment for Cervicitis
2005.06.08
Completion of the Clinical Study of Eye-gel
2005.05.09
Market Isosorbide Mononitrate in HK and China
2005.03.29
Progress in Clinical Study of Eye-gel
2005.03.16
Good progress in Clinical Study in Cervicitis
2005.02.04
© Lee's Pharmaceutical Holdings Limited
Terms of Use
|
Privacy Statement
Designed by YSD